From their early successes in medicine, organometallic compounds continue to attract interest as potential chemotherapeutics to treat a range of diseases. Here, we show from recent literature selected largely from the last two years that organometallics offer unique opportunities in medicine and, increasingly, a mechanistic-based approach is applied to their development, which has not always been the case.
Murray, B. S., & Dyson, P. J. (2020). Recent progress in the development of organometallics for the treatment of cancer. Current opinion in chemical biology, 56, 28-34. https://doi.org/10.1016/j.cbpa.2019.11.001